Abbott (ABT) Tops Q3 EPS by 20c, Beats on Revenue, Raises FY22 Guidance

Abbott (NYSE: ABT) reported Q3 EPS of $1.15, $0.20 better than the analyst estimate of $0.95. Revenue for the quarter came in at $10.4 billion versus the consensus estimate of $9.63 billion.

GUIDANCE:

Abbott sees FY2022 EPS of $5.17-$5.23, versus the consensus of $5.05.

For earnings history and earnings-related data on Abbott (ABT) click here.

You May Also Be Interested In

• AeroVironment restates quarterly financials, citing $89M goodwill error
• New Similac® survey finds social media pressure to be "perfect" is fueling a shift toward authenticity for the next generation of parents
• Accenture downgraded by TD Cowen on AI concerns